Collegium Pharmaceutical (COLL) SEC Filings & 10K Form

$38.93

-0.41 (-1.04%)

(As of 10/17/2024 ET)

Compare

Recent Collegium Pharmaceutical SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
09/17/2024 3:32 PM	Collegium Pharmaceutical (Issuer) Smith Thomas B (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
09/13/2024 9:39 AM	Collegium Pharmaceutical (Subject) Smith Thomas B (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
09/13/2024 9:06 AM	Collegium Pharmaceutical (Subject) Smith Thomas B (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
09/06/2024 4:52 PM	Collegium Pharmaceutical (Issuer) Kuhlmann Shirley R. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
09/06/2024 10:53 AM	Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
09/05/2024 3:47 PM	Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
09/04/2024 7:03 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
Get the Latest News and Ratings for COLL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.
08/12/2024 1:41 PM	Collegium Pharmaceutical (Subject) McFarlane Neil F. (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
08/09/2024 3:34 PM	Collegium Pharmaceutical (Subject) McFarlane Neil F. (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
07/29/2024 5:02 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/13/2024 7:05 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/05/2024 3:50 PM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
06/04/2024 3:36 PM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject) Collegium Pharmaceutical (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
06/03/2024 4:22 PM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
06/03/2024 12:59 PM	Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
05/30/2024 12:11 PM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
05/29/2024 10:19 AM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)	Form 144/A
05/29/2024 9:05 AM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
05/28/2024 3:22 PM	Collegium Pharmaceutical (Issuer) Dreyer Scott (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/28/2024 11:12 AM	Collegium Pharmaceutical (Subject) Tupper Colleen (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
05/28/2024 9:05 AM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
05/24/2024 3:05 PM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/24/2024 12:01 PM	Collegium Pharmaceutical (Subject) Dreyer Scott (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
05/16/2024 6:20 PM	BOHLIN GAREN G (Reporting) Collegium Pharmaceutical (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
05/16/2024 6:21 PM	Collegium Pharmaceutical (Issuer) Heffernan Michael Thomas (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/16/2024 6:22 PM	Balice-Gordon Rita J. (Reporting) Collegium Pharmaceutical (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
05/16/2024 6:22 PM	Collegium Pharmaceutical (Issuer) Fallon John A. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/16/2024 6:22 PM	Collegium Pharmaceutical (Issuer) Freund John Gordon (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/16/2024 6:23 PM	Collegium Pharmaceutical (Issuer) McFarlane Neil F. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/16/2024 6:23 PM	Collegium Pharmaceutical (Issuer) Melincoff Gwen A (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/16/2024 6:23 PM	Collegium Pharmaceutical (Issuer) SANTINI GINO (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/14/2024 2:12 PM	BOHLIN GAREN G (Reporting) Collegium Pharmaceutical (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
05/13/2024 7:05 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/10/2024 7:02 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/10/2024 7:03 AM	Collegium Pharmaceutical (Filer)	Form DEFA14A
05/09/2024 3:07 PM	Collegium Pharmaceutical (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
04/29/2024 7:05 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/11/2024 7:00 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/04/2024 3:26 PM	Collegium Pharmaceutical (Issuer) Smith Thomas B (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/29/2024 4:24 PM	Collegium Pharmaceutical (Subject) Smith Thomas B (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
02/28/2024 3:14 PM	Collegium Pharmaceutical (Issuer) Dreyer Scott (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad) The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future. Take these 4 steps today to protect your retirement NOW
02/26/2024 3:39 PM	Collegium Pharmaceutical (Subject) Dreyer Scott (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
02/14/2024 11:04 AM	Collegium Pharmaceutical (Subject) EVENTIDE ASSET MANAGEMENT, LLC (Filed by)	Form SC 13G/A
02/12/2024 5:06 AM	Collegium Pharmaceutical (Subject) Rubric Capital Management LP (Filed by)	Form SC 13G/A
01/19/2024 1:40 PM	BlackRock Inc. (Filed by) Collegium Pharmaceutical (Subject)	Form SC 13G/A
01/18/2024 3:19 PM	Collegium Pharmaceutical (Issuer) Dreyer Scott (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
01/03/2024 7:03 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
12/22/2023 3:36 PM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
12/20/2023 4:51 PM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
12/20/2023 3:28 PM	Ciaffoni Joseph (Reporting) Collegium Pharmaceutical (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
11/29/2023 3:32 PM	Collegium Pharmaceutical (Issuer) Kuhlmann Shirley R. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
11/27/2023 4:00 PM	Collegium Pharmaceutical (Subject) Kuhlmann Shirley R. (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
11/09/2023 7:05 AM	Collegium Pharmaceutical (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)